Home›Companies›Healthcare›Valera Health

Valera Health, Inc.

Updated Oct 27, 2026·Latest SEC filing Jan 13, 2025·Suggest an edit

About Valera Health

Valera Health is a private company based in Brooklyn, New York. It has reported $73,848,603 raised in four offerings on Form D since January 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 26, 2024Apr 9, 2024amended Jan 13, 2025$9,602,465of $18.9M target23$417KEquity, OptionsRule 506(b)Form D/A ↗1 earlier filing
Aug 30, 2022Oct 7, 2022$44,539,475fully sold12$3.7MEquityRule 506(b)Form D ↗
Sep 22, 2021Nov 4, 2021$14,999,997fully sold16$937KEquityRule 506(b)Form D ↗
Dec 17, 2020Jan 5, 2021$4,706,666of $4.8M target12$392KEquityRule 506(b)Form D ↗
Total, four offerings$73,848,603

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Valera Health's Form D filed Jan 13, 2025.

AF
Adam Fine
Director
CA
Craig Albright
Executive officer and director
JN
LB
MA

Earlier filings also listed Thomas Tsang (chief executive officer and director, last listed Oct 2022), Ofer Sharon (director, last listed Oct 2022), Arick Rynearson (director, last listed Oct 2022) and Matthew Whitman (director, last listed Nov 2021).

Sources

  1. SECValera Health, Inc. Form D, filed Apr 9, 2024
  2. SECValera Health, Inc. filing history